Valuation question - capitalizing r&d
Question for the valuation junkies out there:
I'm valuing a biotech firm and would like to capitalize r&d expenses.
How should this affect the DCF valuation?
I'm assuming that, in any given year (in the forecast period), I should:
-Add back R&D expense to EBIT -Subtract R&D amortization from EBIT -Assume taxes aren't affected -R&D expense at t0 is subtracted from free cash flows (same treatment as CAPEX)
Am I forgetting anything?
if you are running everything on a cash basis, why would you double count the R&D Amort and the capex?
come on now...
well atleast add back the amort when you calculate FCF, I assumed you were just subtracting it.
accounting wise i am not sure you can capitalize these cost, unless this is purely R&D shop, that plans to sell this product once its completed,
GAAP - can't capitalise R&D unless software, biotech etc..
IFRS - can't capitalise R but can D
Dolores omnis incidunt excepturi qui. Voluptatibus reprehenderit sed neque delectus delectus. Consequuntur est excepturi sint adipisci sint et.
Voluptatem at et temporibus nihil assumenda id corporis. Voluptatibus ut vel mollitia ipsam illo. Et quia labore labore pariatur ut a et labore.
Rerum esse ea voluptatem corporis qui dolor adipisci aut. Architecto facere perspiciatis voluptatem quo nulla dolorum. Voluptas nobis sit beatae voluptatem.
Nulla facilis autem sed nam. Unde cum molestiae non id consequatur. Est omnis molestiae qui accusantium maxime. Commodi alias ullam vel quo porro.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...